QRPH Tech Minutes 2013-04-05: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 21: | Line 21: | ||
*Jen Foltz | *Jen Foltz | ||
*Nichole Drye-Mayo | *Nichole Drye-Mayo | ||
==Minutes== | |||
*Actor Groupings | |||
**ACTION: Steve Moore will put together a CP to present to ITI at next f2f end of April | |||
**ACTION: Add this topic to April/May f2f meeting agenda during joint mtg time with ITI | |||
*Follow up with CDC (Wendy Blumenthal) regarding PRPH-Ca and the new RFD actors and implications | |||
**Discuss w/Wendy modifying existing PRPH-CA profile to reference document specification written for CDC and only include Volume 1 (need to figure out what we do with Cancer – need to realign); Volume yet to be determined; ongoing discussion item | |||
*Tcon Recording | |||
**[https://ihe.webex.com/ihe/lsr.php?AT=pb&SP=MC&rID=66457807&rKey=d2e91c9083581e33] | |||
Latest revision as of 15:45, 5 April 2013
Attendees
- Landen Bain
- Didi Davis
- Ann Kreeger
- Chris Melo
- Harry Solomon
- Paul Dow
- John Eichwald
- John Stamm
- Ken Pool
- Lori Fourquet
- Lisa Nelson
- Mead Walker
- Michelle Williamson
- Stan Haavik
- Steve Moore
- Wendy Blumenthal
- Kevin O'Donnell
- Nichole Kallas
- Scott Graunke
- Jen Foltz
- Nichole Drye-Mayo
Minutes
- Actor Groupings
- ACTION: Steve Moore will put together a CP to present to ITI at next f2f end of April
- ACTION: Add this topic to April/May f2f meeting agenda during joint mtg time with ITI
- Follow up with CDC (Wendy Blumenthal) regarding PRPH-Ca and the new RFD actors and implications
- Discuss w/Wendy modifying existing PRPH-CA profile to reference document specification written for CDC and only include Volume 1 (need to figure out what we do with Cancer – need to realign); Volume yet to be determined; ongoing discussion item
- Tcon Recording